EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy

Sara Pagotto iD, Pasquale Simeone iD, Davide Brocco iD, Giulia Catitti, Domenico De Bellis iD, Simone Vespa, Natalia Di Pietro iD, Lisa Marinelli, Antonio Di Stefano, Serena Veschi iD, Laura De Lellis iD, Fabio Verginelli iD und 10 weitere

Cancers · 07.02.2023 · 15 (4) · 1052

DOI: 10.3390/cancers15041052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.02.2023. Verfasst von Sara Pagotto und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Oral and Biotechnological Sciences, "G.d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are a heterogenous population of plasma membrane-surrounded particles that are released in the extracellular milieu by almost all types of living cells. EVs are key players in intercellular crosstalk, both locally and systemically, given that they deliver their cargoes (consisting of proteins, lipids, mRNAs, miRNAs, and DNA fragments) to target cells, crossing biological barriers. Those mechanisms further trigger a wide range of biological responses. Interestingly, EV phenotypes and cargoes and, therefore, their functions, stem from their specific parental cells. For these reasons, EVs have been proposed as promising candidates for EV-based, cell-free therapies. One of the new frontiers of cell-based immunotherapy for the fight against refractory neoplastic diseases is represented by genetically engineered chimeric antigen receptor T (CAR-T) lymphocytes, which in recent years have demonstrated their effectiveness by reaching commercialization and clinical application for some neoplastic diseases. CAR-T-derived EVs represent a recent promising development of CAR-T immunotherapy approaches. This crosscutting innovative strategy is designed to exploit the advantages of genetically engineered cell-based immunotherapy together with those of cell-free EVs, which in principle might be safer and more efficient in crossing biological and tumor-associated barriers. In this review, we underlined the potential of CAR-T-derived EVs as therapeutic agents in tumors.

Schlagwörter

Stichwörter der Autor:innen

CAR-T cellsanti-tumor agentsextracellular vesiclestumors

Autor:innen und Institutionen

  • Department of Medical, Oral and Biotechnological Sciences, "G.d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Center for Advanced Studies and Technology (CAST), "G.d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Department of Medicine and Aging Sciences, "G.d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Department of Pharmacy, "G.d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Sacred Heart Catholic University, 00168 Rome, Italy.
  • Department of Neuroscience, Imaging and Clinical Sciences, "G.d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.

ORCID-Profile: Sara Pagotto, Pasquale Simeone, Davide Brocco, Domenico De Bellis, Natalia Di Pietro, Serena Veschi, Laura De Lellis, Fabio Verginelli, Manuela Iezzi, Nicola Tinari, Ignazio Caruana, Mauro Di Ianni, Alessandro Cama, Paola Lanuti, Rosalba Florio

Förderung

  • Italian Ministry of University and Research

Zitieren

APA

Pagotto, S., Simeone, P., Brocco, D., Catitti, G., De Bellis, D., Vespa, S., Di Pietro, N., Marinelli, L., Di Stefano, A., Veschi, S., De Lellis, L., Verginelli, F., Kaitsas, F., Iezzi, M., Pandolfi, A., Visone, R., Tinari, N., Caruana, I., Di Ianni, M., …, & Florio, R. (2023). CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy. Cancers, 15(4), 1052. https://doi.org/10.3390/cancers15041052

Vancouver

Pagotto S, Simeone P, Brocco D, Catitti G, De Bellis D, Vespa S, et al. CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy. Cancers. 2023;15(4):1052. doi:10.3390/cancers15041052

BibTeX
@article{Pagotto2023,
  author = {Pagotto, Sara and Simeone, Pasquale and Brocco, Davide and Catitti, Giulia and De Bellis, Domenico and Vespa, Simone and Di Pietro, Natalia and Marinelli, Lisa and Di Stefano, Antonio and Veschi, Serena and De Lellis, Laura and Verginelli, Fabio and Kaitsas, Francesco and Iezzi, Manuela and Pandolfi, Assunta and Visone, Rosa and Tinari, Nicola and Caruana, Ignazio and Di Ianni, Mauro and Cama, Alessandro and Lanuti, Paola and Florio, Rosalba},
  title = {CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1052},
  doi = {10.3390/cancers15041052}
}
Kostenlos starten →